US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CINGULATE INC.

4.24

+0.06001.44%

Post-market: 4.240.00000.00%19:33 EDT

Volume:61.15K

Turnover:252.95K

Market Cap:15.98M

PE:-0.42

High:4.27

Open:4.20

Low:4.04

Close:4.18

Loading ...

Overview Company News Filings

Cingulate Inc Secures $3M Grant for Anxiety Drug

Cingulate receives $3M grant from to accelerate development of CTx-2103

Press Release: Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)

Roth MKM Keeps Their Buy Rating on Cingulate Inc (CING)

BRIEF-Cingulate Completes Pre-NDA Meeting With FDA To Discuss New Drug Application For Lead ADHD Asset CTX-1301

Cingulate Completes Pre-Nda Meeting With FDA to Discuss New Drug Application for Lead Adhd Asset Ctx-1301

THOMSON REUTERS

Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301

Cingulate Inc. Reports 2024 Financial and Development Milestones

Cingulate Q4 Net loss $(6.1)M Up From $(6.9)M YoY

Press Release: Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved

CING: April Pre-NDA Meeting

Zacks Small Cap Research

Calendar of U.S. Earnings Expected in the Week Ahead

Cingulate Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Promising Prospects for Cingulate Inc.: Buy Rating Backed by Positive Phase 3 Results and Market Potential of CTx-1301

Roth MKM Reaffirms Their Buy Rating on Cingulate Inc (CING)

Cingulate Inc. Advances Towards FDA Approval for CTx-1301

Cingulate reports safety results from final Phase 3 trials for CTx-1301

BRIEF-Cingulate Reports Safety Results From Final Phase 3 Trials For Lead ADHD Asset CTX-1301

Cingulate Reports Safety Results From Final Phase 3 Trials for Lead Adhd Asset Ctx-1301: on Track to File for FDA Approval Mid-2025

THOMSON REUTERS

Cingulate Inc - No Serious Adverse Events Reported in Ctx-1301 Studies

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CING/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CING","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CING\",,,,,undefined,":{"symbol":"CING","market":"US","secType":"STK","nameCN":"CINGULATE INC.","latestPrice":4.24,"timestamp":1744920000000,"preClose":4.18,"halted":0,"volume":61148,"hourTrading":{"tag":"盘后","latestPrice":4.24,"preClose":4.24,"latestTime":"19:33 EDT","volume":73,"amount":309.3675,"timestamp":1744932816701},"delay":0,"floatShares":3759297,"shares":3768400,"eps":-10.195283,"marketStatus":"Market Closed","change":0.06,"latestTime":"04-17 16:00:00 EDT","open":4.2,"high":4.2699,"low":4.0402,"amount":252950.19782400003,"amplitude":0.054952,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.195283,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1633579200000,"exchange":"NASDAQ","adjPreClose":4.18,"postHourTrading":{"tag":"盘后","latestPrice":4.24,"preClose":4.24,"latestTime":"19:33 EDT","volume":73,"amount":309.3675,"timestamp":1744932816701},"volumeRatio":0.7852937848492836},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CING\",,,,,undefined,":{"symbol":"CING","floatShares":3759297,"roa":"-106.54%","roe":"-5305.02%","lyrEps":-10.195283,"volumeRatio":0.7852937848492836,"shares":3768400,"dividePrice":0,"high":4.2699,"amplitude":0.054952,"preClose":4.18,"low":4.0402,"week52Low":1.8001,"pbRate":"2.14","week52High":20.83,"institutionHeld":0,"latestPrice":4.24,"eps":-10.195283,"divideRate":0,"volume":61148,"delay":0,"ttmEps":-10.195283,"open":4.2,"prevYearClose":4.93,"prevWeekClose":3.8,"prevMonthClose":4.3,"prevQuarterClose":4.3,"fiveDayClose":3.66,"twentyDayClose":4.09,"sixtyDayClose":5.03},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CING\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526366552","title":"Cingulate Inc Secures $3M Grant for Anxiety Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2526366552","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526366552?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:28","pubTimestamp":1744201729,"startTime":"0","endTime":"0","summary":"The latest update is out from Cingulate Inc ( ($CING) ). On April 8, 2025, Cingulate Inc. entered into a Grant Agreement with a private foundation ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cingulate-inc-secures-3m-grant-for-anxiety-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cingulate-inc-secures-3m-grant-for-anxiety-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4533","BK4206","LU1894683264.USD","BK4588","CING","LU0787776722.HKD","LU1894683348.USD","LU1093756168.USD","LU1093756325.SGD","MMM","LU0683600562.USD","BK4512","BK4534","BK4007"],"gpt_icon":0},{"id":"2526809365","title":"Cingulate receives $3M grant from to accelerate development of CTx-2103","url":"https://stock-news.laohu8.com/highlight/detail?id=2526809365","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526809365?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:17","pubTimestamp":1744201030,"startTime":"0","endTime":"0","summary":"Cingulate (CING) has received a $3M grant to accelerate the development of CTx-2103 for the treatment of anxiety. CTx-2103 has the potential to be ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cingulate-receives-3m-grant-from-to-accelerate-development-of-ctx-2103?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cingulate-receives-3m-grant-from-to-accelerate-development-of-ctx-2103?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","BK4007","LU0787776722.HKD","LU1093756325.SGD","LU1894683264.USD","BK4534","BK4588","LU0683600562.USD","CING","LU1093756168.USD","BK4585","BK4206","LU1894683348.USD","MMM","BK4512"],"gpt_icon":0},{"id":"2526419368","title":"Press Release: Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526419368","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526419368?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:00","pubTimestamp":1744200000,"startTime":"0","endTime":"0","summary":"Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 . CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in the $5.5 Billion U.S. Anxiety Market, and the $11.6 Billion Anxiety Market Worldwide. Non-Dilutive Funding Expands Pipeline and Further Validates Cingulate's Proprietary Precision Timed Release Drug Delivery Technology. CTx-2103 has the Potential to Reduce Use of Benzodiazepine's and Associated Withdrawal and Dependency Issues. CTx-2103 is a novel, multi-release tablet of buspirone that incorporates Cingulate's proprietary PTR drug delivery platform. CTx-2103 is being studied for the treatment of anxiety and/or anxiety-related disorders. Buspirone, an azapirone derivative and a 5-HT1A partial agonist, was the first non-benzodiazepine anxiolytic introduced for the","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4555","BK4588","AAQC","CING","BK4585","03160","BK4604","TM","BK4007"],"gpt_icon":0},{"id":"2524201409","title":"Roth MKM Keeps Their Buy Rating on Cingulate Inc (CING)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524201409","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524201409?lang=en_us&edition=fundamental","pubTime":"2025-04-04 20:55","pubTimestamp":1743771356,"startTime":"0","endTime":"0","summary":"In a report released today, Boobalan Pachaiyappan from Roth MKM maintained a Buy rating on Cingulate Inc (CING – Research Report), with a price tar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-keeps-their-buy-rating-on-cingulate-inc-cing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-keeps-their-buy-rating-on-cingulate-inc-cing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING"],"gpt_icon":0},{"id":"2524256918","title":"BRIEF-Cingulate Completes Pre-NDA Meeting With FDA To Discuss New Drug Application For Lead ADHD Asset CTX-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2524256918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524256918?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:09","pubTimestamp":1743682191,"startTime":"0","endTime":"0","summary":"BRIEF-Cingulate Completes Pre-NDA Meeting With FDA To Discuss New Drug Application For Lead ADHD Asset CTX-1301April 3 (Reuters) - Cingulate Inc CING.O:CINGULATE COMPLETES PRE-NDA MEETING WITH FDA TO ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250403:nTUA2XSGSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","CINGW","BK4007"],"gpt_icon":0},{"id":"2524325578","title":"Cingulate Completes Pre-Nda Meeting With FDA to Discuss New Drug Application for Lead Adhd Asset Ctx-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2524325578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524325578?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:00","pubTimestamp":1743681603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250403:nTUA2XSGSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CING","CINGW"],"gpt_icon":0},{"id":"2524184251","title":"Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2524184251","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524184251?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:00","pubTimestamp":1743681600,"startTime":"0","endTime":"0","summary":"“Our meeting with the FDA yesterday was very productive, and we remain on track for an NDA filing of CTx-1301 in mid-2025. We truly appreciate the FDA personnel who have been involved with the regulatory review of CTx-1301 to date. These interactions have been essential in helping us generate data to demonstrate the consistency and therapeutic benefit of our product. This important milestone is validation of our mission to bring to market the first, true, once-daily stimulant medication to treat ADHD over the entire active day,” said Cingulate Chairman and CEO Shane J Schaffer.About CTx-1301Cingulate’s lead candidate, CTx-1301, utilizes Cingulate’s proprietary PTR drug delivery platform to create a breakthrough, multi-core formulation of the active pharmaceutical ingredient dexmethylphenidate, a compound approved by the FDA for the treatment of ADHD. Dexmethylphenidate is part of the stimulant class of medicines and increases norepinephrine and dopamine activity in the brain to affect ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cingulate-completes-pre-nda-meeting-120000674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ABVC","ADHD","CING","BK4139","CINGW"],"gpt_icon":0},{"id":"2522960055","title":"Cingulate Inc. Reports 2024 Financial and Development Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2522960055","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522960055?lang=en_us&edition=fundamental","pubTime":"2025-03-28 12:02","pubTimestamp":1743134547,"startTime":"0","endTime":"0","summary":"Cingulate, Inc. ( ($CING) ) has released its Q4 earnings. Here is a breakdown of the information Cingulate, Inc. presented to its investors. Cingul...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cingulate-inc-reports-2024-financial-and-development-milestones?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cingulate-inc-reports-2024-financial-and-development-milestones?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING","BK4007"],"gpt_icon":0},{"id":"2522563983","title":"Cingulate Q4 Net loss $(6.1)M Up From $(6.9)M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2522563983","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522563983?lang=en_us&edition=fundamental","pubTime":"2025-03-27 05:10","pubTimestamp":1743023404,"startTime":"0","endTime":"0","summary":"Cingulate Q4 Net loss $(6.1)M Up From $(6.9)M YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44504639/cingulate-q4-net-loss-6-1-m-up-from-6-9-m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","BK4007"],"gpt_icon":0},{"id":"2522416355","title":"Press Release: Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved","url":"https://stock-news.laohu8.com/highlight/detail?id=2522416355","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522416355?lang=en_us&edition=fundamental","pubTime":"2025-03-27 05:00","pubTimestamp":1743022800,"startTime":"0","endTime":"0","summary":"Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved. In-Person FDA Meeting Scheduled for April 2; New Drug Application Submission Targeted for Mid-2025. $17.5 million increase in Working Capital; Cash Runway Extending into Q4, Well Beyond Target Date for NDA Submission. \"The capital raised over the past year has allowed us to strengthen our balance sheet and complete all required clinical trials for NDA submission for CTx-1301. We look forward to meeting with the FDA next week, submitting our new drug application this summer, and, assuming approval by the FDA, bringing to market the first, true, once-daily stimulant medication to treat ADHD over the entire active day,\" said Cingulate Chairman and CEO Shane J Schaffer.and adolescent studies -- a fixed dose study and a dose optimization. treatment emergent adverse events and confirming that the safety profile. and pediatric safety data will be prepared and included i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CING","TM","BK4099","BK4588","03160","BK4604","BK4007","BK4555","ABVC","BK4585"],"gpt_icon":0},{"id":"2518922748","title":"CING: April Pre-NDA Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2518922748","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518922748?lang=en_us&edition=fundamental","pubTime":"2025-03-10 17:40","pubTimestamp":1741599600,"startTime":"0","endTime":"0","summary":"Since the report of third quarter results, Cingulate, Inc.  has executed a $5 million capital raise, completed its fast-fed study and reported safety results from its Phase III trials. As we move down the home stretch towards the FDA submission, Cingulate has a pre-new drug application  meeting scheduled for early April and anticipates filing its NDA with the agency by mid-2025. We also expect to see further safety data from the consolidated Phase III studies at an upcoming but as yet unidentified scientific conference.The pathway forward for FDA submission includes several parallel efforts which include updating stability data on 2024 batches of CTx-1301, completing the analysis of the fast fed study and attendance at the pre-NDA meeting with the FDA in early April. Notes from the meeting are expected about a month later, which will provide final details required for completing the NDA. NDA submission is expected by mid-2025. We anticipate a 10-to-12-month turnaround time by the agenc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cing-april-pre-nda-meeting-094000188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4503","BK4007","BK4181","CMAX","API","BK4551","CINGW","CING","PK","BK4535","BK4023","BK4196","BK4218"],"gpt_icon":0},{"id":"2517859394","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2517859394","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517859394?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:00","pubTimestamp":1741345200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Algonquin Pwr & Utl                              4Q       .09       BMO. ·Asana Inc. Class A                              4Q      (.01)  4:05 PM. ·Auna S.A. Class A                               4Q       .15       AMC. ·Vail Resorts Inc.                                2Q      6.29   4:05 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACET","AUNA","KALV","EWCZ","EVEX","LEN.B","ORCL","CVGW","BW","CDTX","LE","TBRG","AMRN","BDTX","MOMO","CHRS","BNTX","CING","FERG","DKS","AURA","MGTX","NKTR","BBCP","MYPS","ARCO","ASRT","WEST","DRUG","ADBE","ATLC","FTCI","LRMR","AEO","DRRX","GECC","SSP","CINT","ZVRA","BTMD","NOA","URGN","CIEN","KRMD","HLLY","BWMN","SFIX","LMB","VTS"],"gpt_icon":1},{"id":"2517154709","title":"Cingulate Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154709","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154709?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:44","pubTimestamp":1741265040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CING/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2025 07:44 ET (12:44 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING"],"gpt_icon":0},{"id":"2517944262","title":"Promising Prospects for Cingulate Inc.: Buy Rating Backed by Positive Phase 3 Results and Market Potential of CTx-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2517944262","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517944262?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:45","pubTimestamp":1741193132,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Naz Rahman from Maxim Group reiterated a Buy rating on Cingulate Inc (CING – Research Report), with a price target ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-prospects-for-cingulate-inc-buy-rating-backed-by-positive-phase-3-results-and-market-potential-of-ctx-1301?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-prospects-for-cingulate-inc-buy-rating-backed-by-positive-phase-3-results-and-market-potential-of-ctx-1301?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING"],"gpt_icon":0},{"id":"2517914798","title":"Roth MKM Reaffirms Their Buy Rating on Cingulate Inc (CING)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517914798","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517914798?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:37","pubTimestamp":1741181832,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Boobalan Pachaiyappan maintained a Buy rating on Cingulate Inc (CING – Research Report) today and set a price target of $12.00. Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-cingulate-inc-cing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-cingulate-inc-cing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING"],"gpt_icon":0},{"id":"2516677738","title":"Cingulate Inc. Advances Towards FDA Approval for CTx-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677738","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516677738?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:29","pubTimestamp":1741098563,"startTime":"0","endTime":"0","summary":"An update from Cingulate Inc ( ($CING) ) is now available. On March 4, 2025, Cingulate Inc. announced the safety results from its final Phase 3 tri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cingulate-inc-advances-towards-fda-approval-for-ctx-1301?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cingulate-inc-advances-towards-fda-approval-for-ctx-1301?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING","BK4007"],"gpt_icon":0},{"id":"2516521674","title":"Cingulate reports safety results from final Phase 3 trials for CTx-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2516521674","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516521674?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:07","pubTimestamp":1741097232,"startTime":"0","endTime":"0","summary":"Cingulate (CING) released Phase 3 safety data for its lead asset CTx-1301 for the treatment of Attention Deficit Hyperactivity Disorder, ADHD. The ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cingulate-reports-safety-results-from-final-phase-3-trials-for-ctx-1301?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cingulate-reports-safety-results-from-final-phase-3-trials-for-ctx-1301?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVC","BK4007","CING","BK4139"],"gpt_icon":0},{"id":"2516710026","title":"BRIEF-Cingulate Reports Safety Results From Final Phase 3 Trials For Lead ADHD Asset CTX-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2516710026","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516710026?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:05","pubTimestamp":1741097119,"startTime":"0","endTime":"0","summary":"BRIEF-Cingulate Reports Safety Results From Final Phase 3 Trials For Lead ADHD Asset CTX-1301 March 4 (Reuters) - Cingulate Inc CING.O:CINGULATE REPORTS SAFETY RESULTS FROM FINAL PHASE 3 TRIALS FOR LE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA1BQKMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CING","CINGW"],"gpt_icon":0},{"id":"2516967121","title":"Cingulate Reports Safety Results From Final Phase 3 Trials for Lead Adhd Asset Ctx-1301: on Track to File for FDA Approval Mid-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516967121","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516967121?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:00","pubTimestamp":1741096802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA1BQKMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CINGW","BK4007","CING"],"gpt_icon":0},{"id":"2516671786","title":"Cingulate Inc - No Serious Adverse Events Reported in Ctx-1301 Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2516671786","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516671786?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:00","pubTimestamp":1741096802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA1BQKMZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CINGW","BK4007","CING"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CING\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-09","symbol":"CING","defaultRemindTime":1723210200000,"type":"split","dateTimestamp":1723176000000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2023-11-30","symbol":"CING","defaultRemindTime":1701354600000,"type":"split","dateTimestamp":1701320400000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CING\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CING\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1738296000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CING\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CING","date":"2025-04-17","current":-1.013262,"percent":0.089461,"low":-33.556234,"twenty":-0.85189,"median":-0.649841,"eighty":-0.354862,"high":-0.074542,"avg":-0.865458,"sd":2.586982,"marketCap":15751912},"quantilePoints":[{"date":"2021-10-08","current":-33.556234,"twenty":-33.556234,"median":-33.556234,"eighty":-33.556234,"marketCap":171162464},{"date":"2021-10-15","current":-27.455101,"twenty":-33.556234,"median":-30.505668,"eighty":-27.455101,"marketCap":140042016},{"date":"2021-12-10","current":-2.162019,"twenty":-33.556234,"median":-27.455101,"eighty":-2.614398,"marketCap":41618636},{"date":"2021-12-17","current":-1.521639,"twenty":-27.455101,"median":-3.069714,"eighty":-1.815391,"marketCap":29291377},{"date":"2021-12-23","current":-1.498138,"twenty":-27.455101,"median":-2.223707,"eighty":-1.598014,"marketCap":28839000},{"date":"2021-12-31","current":-1.621514,"twenty":-27.455101,"median":-1.815391,"eighty":-1.551014,"marketCap":31213977},{"date":"2022-01-07","current":-1.445263,"twenty":-8.311045,"median":-1.680265,"eighty":-1.516939,"marketCap":27821153},{"date":"2022-01-14","current":-1.527514,"twenty":-3.525031,"median":-1.618166,"eighty":-1.496963,"marketCap":29404471},{"date":"2022-01-21","current":-1.374762,"twenty":-2.978651,"median":-1.568639,"eighty":-1.487563,"marketCap":26464024},{"date":"2022-01-28","current":-1.051634,"twenty":-2.416996,"median":-1.556889,"eighty":-1.445263,"marketCap":20243847},{"date":"2022-02-04","current":-1.075135,"twenty":-2.211369,"median":-1.527514,"eighty":-1.297212,"marketCap":20696223},{"date":"2022-02-11","current":-0.887133,"twenty":-1.978718,"median":-1.521639,"eighty":-1.105685,"marketCap":17077212},{"date":"2022-02-18","current":-0.851883,"twenty":-1.831841,"median":-1.498138,"eighty":-1.065735,"marketCap":16398647},{"date":"2022-02-25","current":-0.810757,"twenty":-1.794241,"median":-1.480513,"eighty":-1.001109,"marketCap":15606988},{"date":"2022-03-04","current":-0.752007,"twenty":-1.741366,"median":-1.451138,"eighty":-0.873033,"marketCap":14476047},{"date":"2022-03-11","current":-0.649841,"twenty":-1.68614,"median":-1.43645,"eighty":-0.848358,"marketCap":13458200},{"date":"2022-03-18","current":-1.010257,"twenty":-1.63914,"median":-1.280762,"eighty":-0.822507,"marketCap":20922412},{"date":"2022-03-25","current":-1.163161,"twenty":-1.620175,"median":-1.141317,"eighty":-0.842482,"marketCap":24089047},{"date":"2022-04-01","current":-1.010257,"twenty":-1.617155,"median":-1.117867,"eighty":-0.848358,"marketCap":20922412},{"date":"2022-04-08","current":-1.015718,"twenty":-1.596839,"median":-1.098635,"eighty":-0.851883,"marketCap":21035506},{"date":"2022-04-14","current":-0.96657,"twenty":-1.567464,"median":-1.086885,"eighty":-0.853058,"marketCap":20017659},{"date":"2022-04-22","current":-0.906501,"twenty":-1.561589,"median":-1.075135,"eighty":-0.858933,"marketCap":18773623},{"date":"2022-04-29","current":-0.884657,"twenty":-1.556889,"median":-1.05935,"eighty":-0.858933,"marketCap":18321247},{"date":"2022-05-06","current":-0.764519,"twenty":-1.552189,"median":-1.045759,"eighty":-0.847183,"marketCap":15833176},{"date":"2022-05-13","current":-0.579861,"twenty":-1.532214,"median":-1.026639,"eighty":-0.798804,"marketCap":14136765},{"date":"2022-05-20","current":-0.552028,"twenty":-1.527514,"median":-1.015718,"eighty":-0.780997,"marketCap":13458200},{"date":"2022-05-27","current":-0.524194,"twenty":-1.526339,"median":-1.010257,"eighty":-0.764519,"marketCap":12779635},{"date":"2022-06-03","current":-0.613493,"twenty":-1.521639,"median":-1.010257,"eighty":-0.742675,"marketCap":14956697},{"date":"2022-06-10","current":-0.649444,"twenty":-1.521639,"median":-0.980222,"eighty":-0.705006,"marketCap":15833176},{"date":"2022-06-17","current":-0.672639,"twenty":-1.515763,"median":-0.972031,"eighty":-0.649841,"marketCap":16398647},{"date":"2022-06-24","current":-0.677278,"twenty":-1.501663,"median":-0.957634,"eighty":-0.649841,"marketCap":16511741},{"date":"2022-07-01","current":-0.686555,"twenty":-1.493438,"median":-0.937113,"eighty":-0.651379,"marketCap":16737929},{"date":"2022-07-08","current":-0.742222,"twenty":-1.485213,"median":-0.925613,"eighty":-0.655939,"marketCap":18095059},{"date":"2022-07-15","current":-0.728305,"twenty":-1.473463,"median":-0.90104,"eighty":-0.661505,"marketCap":17755776},{"date":"2022-07-22","current":-0.654083,"twenty":-1.461713,"median":-0.881927,"eighty":-0.656866,"marketCap":15946270},{"date":"2022-07-29","current":-0.570583,"twenty":-1.449963,"median":-0.863633,"eighty":-0.649682,"marketCap":13910576},{"date":"2022-08-05","current":-0.79325,"twenty":-1.445263,"median":-0.851887,"eighty":-0.649444,"marketCap":19339094},{"date":"2022-08-12","current":-0.691445,"twenty":-1.439975,"median":-0.846008,"eighty":-0.649444,"marketCap":18660529},{"date":"2022-08-19","current":-0.624396,"twenty":-1.399437,"median":-0.811281,"eighty":-0.634786,"marketCap":16851023},{"date":"2022-08-26","current":-0.72916,"twenty":-1.367712,"median":-0.797284,"eighty":-0.634786,"marketCap":19678376},{"date":"2022-09-02","current":-0.641158,"twenty":-1.264311,"median":-0.793132,"eighty":-0.639667,"marketCap":17303400},{"date":"2022-09-09","current":-0.649539,"twenty":-1.184371,"median":-0.781141,"eighty":-0.637748,"marketCap":17529588},{"date":"2022-09-16","current":-0.540584,"twenty":-1.154423,"median":-0.775507,"eighty":-0.631938,"marketCap":14589141},{"date":"2022-09-23","current":-0.419058,"twenty":-1.140694,"median":-0.764968,"eighty":-0.624396,"marketCap":11309412},{"date":"2022-09-30","current":-0.448392,"twenty":-1.131646,"median":-0.763757,"eighty":-0.619727,"marketCap":12101070},{"date":"2022-10-07","current":-0.519631,"twenty":-1.118188,"median":-0.756392,"eighty":-0.611749,"marketCap":14023670},{"date":"2022-10-14","current":-0.460963,"twenty":-1.11391,"median":-0.742675,"eighty":-0.5845,"marketCap":12440353},{"date":"2022-10-21","current":-0.469344,"twenty":-1.105685,"median":-0.734823,"eighty":-0.575222,"marketCap":12666541},{"date":"2022-10-28","current":-0.448392,"twenty":-1.098233,"median":-0.72916,"eighty":-0.571993,"marketCap":12101070},{"date":"2022-11-04","current":-0.441687,"twenty":-1.093333,"median":-0.725985,"eighty":-0.563161,"marketCap":11920120},{"date":"2022-11-11","current":-0.44001,"twenty":-1.082446,"median":-0.719028,"eighty":-0.549245,"marketCap":11874882},{"date":"2022-11-18","current":-0.632898,"twenty":-1.075526,"median":-0.714728,"eighty":-0.552479,"marketCap":9952282},{"date":"2022-11-25","current":-0.647282,"twenty":-1.075135,"median":-0.707458,"eighty":-0.552254,"marketCap":10178470},{"date":"2022-12-02","current":-0.695901,"twenty":-1.074173,"median":-0.705006,"eighty":-0.553858,"marketCap":10942987},{"date":"2022-12-09","current":-0.69795,"twenty":-1.068131,"median":-0.700056,"eighty":-0.557594,"marketCap":10975218},{"date":"2022-12-16","current":-0.740779,"twenty":-1.057807,"median":-0.69964,"eighty":-0.562233,"marketCap":11648694},{"date":"2022-12-23","current":-0.687198,"twenty":-1.051634,"median":-0.697627,"eighty":-0.565953,"marketCap":10806143},{"date":"2022-12-30","current":-0.719203,"twenty":-1.051634,"median":-0.697627,"eighty":-0.565991,"marketCap":11309412},{"date":"2023-01-06","current":-0.762355,"twenty":-1.042234,"median":-0.698795,"eighty":-0.569665,"marketCap":11987976},{"date":"2023-01-13","current":-0.706832,"twenty":-1.033657,"median":-0.697627,"eighty":-0.570583,"marketCap":11114890},{"date":"2023-01-20","current":-0.701223,"twenty":-1.028823,"median":-0.697627,"eighty":-0.572699,"marketCap":11026676},{"date":"2023-01-27","current":-0.683602,"twenty":-1.023363,"median":-0.697788,"eighty":-0.574109,"marketCap":10749596},{"date":"2023-02-03","current":-0.712011,"twenty":-1.017902,"median":-0.69795,"eighty":-0.574777,"marketCap":11196317},{"date":"2023-02-10","current":-0.704675,"twenty":-1.015718,"median":-0.700056,"eighty":-0.575222,"marketCap":11080961},{"date":"2023-02-17","current":-0.791123,"twenty":-1.012441,"median":-0.704675,"eighty":-0.575222,"marketCap":12440353},{"date":"2023-02-24","current":-1.121956,"twenty":-1.013534,"median":-0.705006,"eighty":-0.577078,"marketCap":17642682},{"date":"2023-03-03","current":-0.970924,"twenty":-1.024455,"median":-0.710169,"eighty":-0.580913,"marketCap":15267706},{"date":"2023-03-10","current":-1.183647,"twenty":-1.04166,"median":-0.712011,"eighty":-0.583294,"marketCap":20922412},{"date":"2023-03-17","current":-0.592015,"twenty":-1.03677,"median":-0.711183,"eighty":-0.5845,"marketCap":10464598},{"date":"2023-03-24","current":-0.659003,"twenty":-1.029916,"median":-0.706832,"eighty":-0.58398,"marketCap":11648694},{"date":"2023-03-31","current":-0.630212,"twenty":-1.024455,"median":-0.704675,"eighty":-0.5845,"marketCap":11139770},{"date":"2023-04-06","current":-0.620679,"twenty":-1.020087,"median":-0.700848,"eighty":-0.584736,"marketCap":10971260},{"date":"2023-04-14","current":-0.652605,"twenty":-1.015718,"median":-0.69795,"eighty":-0.586373,"marketCap":11535600},{"date":"2023-04-21","current":-0.652605,"twenty":-1.01539,"median":-0.697627,"eighty":-0.589714,"marketCap":11535600},{"date":"2023-04-28","current":-0.684596,"twenty":-1.013312,"median":-0.697627,"eighty":-0.593286,"marketCap":12101070},{"date":"2023-05-05","current":-0.697392,"twenty":-1.010257,"median":-0.697627,"eighty":-0.600272,"marketCap":12327259},{"date":"2023-05-12","current":-0.705244,"twenty":-1.010257,"median":-0.697627,"eighty":-0.608577,"marketCap":11761788},{"date":"2023-05-19","current":-0.679181,"twenty":-1.010257,"median":-0.697627,"eighty":-0.611554,"marketCap":11327111},{"date":"2023-05-26","current":-0.617503,"twenty":-1.008073,"median":-0.696624,"eighty":-0.612565,"marketCap":10298474},{"date":"2023-06-02","current":-0.637364,"twenty":-0.999335,"median":-0.695635,"eighty":-0.613493,"marketCap":10629701},{"date":"2023-06-09","current":-0.682138,"twenty":-0.986229,"median":-0.695635,"eighty":-0.615044,"marketCap":11376426},{"date":"2023-06-16","current":-0.687752,"twenty":-0.978584,"median":-0.695768,"eighty":-0.615898,"marketCap":11470059},{"date":"2023-06-23","current":-0.631609,"twenty":-0.976599,"median":-0.694193,"eighty":-0.615665,"marketCap":10533727},{"date":"2023-06-30","current":-0.645645,"twenty":-0.974613,"median":-0.691445,"eighty":-0.616313,"marketCap":10767810},{"date":"2023-07-07","current":-0.617573,"twenty":-0.972031,"median":-0.69125,"eighty":-0.617503,"marketCap":10299644},{"date":"2023-07-14","current":-0.575466,"twenty":-0.970924,"median":-0.690966,"eighty":-0.615432,"marketCap":9597396},{"date":"2023-07-21","current":-0.542342,"twenty":-0.96657,"median":-0.690435,"eighty":-0.607882,"marketCap":9044960},{"date":"2023-07-28","current":-0.469799,"twenty":-0.957634,"median":-0.687858,"eighty":-0.589139,"marketCap":7835124},{"date":"2023-08-04","current":-0.465402,"twenty":-0.956045,"median":-0.687503,"eighty":-0.5845,"marketCap":7761795},{"date":"2023-08-11","current":-0.454991,"twenty":-0.947836,"median":-0.687198,"eighty":-0.581753,"marketCap":7588158},{"date":"2023-08-18","current":-0.519697,"twenty":-0.931852,"median":-0.686451,"eighty":-0.575222,"marketCap":10005971},{"date":"2023-08-25","current":-0.534418,"twenty":-0.928344,"median":-0.684243,"eighty":-0.570583,"marketCap":10289396},{"date":"2023-09-01","current":-0.522218,"twenty":-0.923975,"median":-0.683423,"eighty":-0.561349,"marketCap":10054514},{"date":"2023-09-08","current":-0.447395,"twenty":-0.913054,"median":-0.683243,"eighty":-0.55391,"marketCap":8613904},{"date":"2023-09-15","current":-0.589599,"twenty":-0.904317,"median":-0.681822,"eighty":-0.550587,"marketCap":11351830},{"date":"2023-09-22","current":-0.686,"twenty":-0.902132,"median":-0.681822,"eighty":-0.551548,"marketCap":13207886},{"date":"2023-09-28","current":-0.613609,"twenty":-0.892696,"median":-0.681089,"eighty":-0.552705,"marketCap":11814106},{"date":"2023-10-05","current":-0.58653,"twenty":-0.886638,"median":-0.680006,"eighty":-0.553407,"marketCap":11292742},{"date":"2023-10-13","current":-0.487421,"twenty":-0.884621,"median":-0.67823,"eighty":-0.550106,"marketCap":9384550},{"date":"2023-10-20","current":-0.413586,"twenty":-0.883419,"median":-0.677278,"eighty":-0.544811,"marketCap":7962965},{"date":"2023-10-27","current":-0.389937,"twenty":-0.881308,"median":-0.677278,"eighty":-0.544129,"marketCap":7507640},{"date":"2023-11-03","current":-0.374501,"twenty":-0.872644,"median":-0.674345,"eighty":-0.540557,"marketCap":7210445},{"date":"2023-11-10","current":-0.360133,"twenty":-0.86549,"median":-0.672109,"eighty":-0.536153,"marketCap":6933802},{"date":"2023-11-17","current":-0.257169,"twenty":-0.863236,"median":-0.668858,"eighty":-0.53123,"marketCap":5453341},{"date":"2023-11-24","current":-0.31585,"twenty":-0.860886,"median":-0.668429,"eighty":-0.524194,"marketCap":6697678},{"date":"2023-12-01","current":-0.277053,"twenty":-0.855412,"median":-0.665401,"eighty":-0.521193,"marketCap":5874990},{"date":"2023-12-08","current":-0.164818,"twenty":-0.851888,"median":-0.665401,"eighty":-0.519446,"marketCap":3495010},{"date":"2023-12-15","current":-0.127701,"twenty":-0.851883,"median":-0.664615,"eighty":-0.511644,"marketCap":2707930},{"date":"2023-12-22","current":-0.090584,"twenty":-0.849533,"median":-0.663089,"eighty":-0.50742,"marketCap":1920850},{"date":"2023-12-29","current":-0.433917,"twenty":-0.846008,"median":-0.659003,"eighty":-0.505223,"marketCap":9201340},{"date":"2024-01-05","current":-0.317705,"twenty":-0.845132,"median":-0.659003,"eighty":-0.499675,"marketCap":6737030},{"date":"2024-01-12","current":-0.468453,"twenty":-0.841898,"median":-0.657279,"eighty":-0.496427,"marketCap":9933671},{"date":"2024-01-19","current":-0.365188,"twenty":-0.83776,"median":-0.65373,"eighty":-0.485067,"marketCap":7743913},{"date":"2024-01-26","current":-0.269446,"twenty":-0.825244,"median":-0.652634,"eighty":-0.473931,"marketCap":5713673},{"date":"2024-02-02","current":-0.229781,"twenty":-0.811386,"median":-0.652605,"eighty":-0.469354,"marketCap":4872574},{"date":"2024-02-09","current":-0.085484,"twenty":-0.808407,"median":-0.652445,"eighty":-0.466657,"marketCap":1812713},{"date":"2024-02-16","current":-0.217565,"twenty":-0.802255,"median":-0.651022,"eighty":-0.462556,"marketCap":4613518},{"date":"2024-02-23","current":-0.208187,"twenty":-0.798109,"median":-0.649895,"eighty":-0.460342,"marketCap":4414659},{"date":"2024-03-01","current":-0.306956,"twenty":-0.796477,"median":-0.64969,"eighty":-0.453064,"marketCap":6509088},{"date":"2024-03-08","current":-0.271582,"twenty":-0.793226,"median":-0.649539,"eighty":-0.449163,"marketCap":5758970},{"date":"2024-03-15","current":-0.273864,"twenty":-0.793132,"median":-0.649444,"eighty":-0.448392,"marketCap":5807365},{"date":"2024-03-22","current":-0.246478,"twenty":-0.79273,"median":-0.649154,"eighty":-0.447462,"marketCap":5226628},{"date":"2024-03-28","current":-0.24876,"twenty":-0.791123,"median":-0.647282,"eighty":-0.444201,"marketCap":5275023},{"date":"2024-04-05","current":-0.227798,"twenty":-0.781382,"median":-0.646574,"eighty":-0.44001,"marketCap":5361203},{"date":"2024-04-12","current":-0.204713,"twenty":-0.780901,"median":-0.645645,"eighty":-0.433575,"marketCap":4817918},{"date":"2024-04-19","current":-0.187348,"twenty":-0.780901,"median":-0.640128,"eighty":-0.42742,"marketCap":4409214},{"date":"2024-04-26","current":-0.215809,"twenty":-0.776739,"median":-0.639809,"eighty":-0.413586,"marketCap":5079042},{"date":"2024-05-03","current":-0.287745,"twenty":-0.776739,"median":-0.639489,"eighty":-0.388132,"marketCap":6772056},{"date":"2024-05-10","current":-0.237801,"twenty":-0.776739,"median":-0.638627,"eighty":-0.374501,"marketCap":5351133},{"date":"2024-05-17","current":-0.212275,"twenty":-0.775507,"median":-0.637095,"eighty":-0.361053,"marketCap":4776718},{"date":"2024-05-24","current":-0.221679,"twenty":-0.766875,"median":-0.635118,"eighty":-0.343,"marketCap":4988345},{"date":"2024-05-31","current":-0.207125,"twenty":-0.765708,"median":-0.632898,"eighty":-0.314502,"marketCap":4660839},{"date":"2024-06-07","current":-0.207356,"twenty":-0.764698,"median":-0.631609,"eighty":-0.3051,"marketCap":4666038},{"date":"2024-06-14","current":-0.212765,"twenty":-0.764519,"median":-0.630212,"eighty":-0.297266,"marketCap":4787761},{"date":"2024-06-21","current":-0.19035,"twenty":-0.764214,"median":-0.628292,"eighty":-0.287229,"marketCap":4283350},{"date":"2024-06-28","current":-0.179326,"twenty":-0.763909,"median":-0.627537,"eighty":-0.282537,"marketCap":4035290},{"date":"2024-07-05","current":-0.108669,"twenty":-0.763114,"median":-0.626298,"eighty":-0.279209,"marketCap":2445325},{"date":"2024-07-12","current":-0.163139,"twenty":-0.762487,"median":-0.624712,"eighty":-0.273922,"marketCap":3671045},{"date":"2024-07-15","current":-0.179035,"twenty":-0.762421,"median":-0.624667,"eighty":-0.273864,"marketCap":4028731},{"date":"2024-08-02","current":-0.155299,"twenty":-0.762355,"median":-0.624621,"eighty":-0.273864,"marketCap":3494630},{"date":"2024-08-09","current":-0.10968,"twenty":-0.762355,"median":-0.624396,"eighty":-0.2693,"marketCap":2468069},{"date":"2024-08-16","current":-0.219061,"twenty":-0.762355,"median":-0.622537,"eighty":-0.265123,"marketCap":4183166},{"date":"2024-08-23","current":-0.564453,"twenty":-0.762355,"median":-0.623466,"eighty":-0.265211,"marketCap":10778738},{"date":"2024-08-30","current":-0.582332,"twenty":-0.760777,"median":-0.620679,"eighty":-0.265211,"marketCap":11120164},{"date":"2024-09-06","current":-0.68717,"twenty":-0.762355,"median":-0.624396,"eighty":-0.266796,"marketCap":13122125},{"date":"2024-09-13","current":-0.678038,"twenty":-0.762355,"median":-0.624396,"eighty":-0.268878,"marketCap":12947744},{"date":"2024-09-20","current":-0.58672,"twenty":-0.761093,"median":-0.622537,"eighty":-0.269417,"marketCap":11203940},{"date":"2024-09-27","current":-0.58672,"twenty":-0.7585,"median":-0.619266,"eighty":-0.270229,"marketCap":11203940},{"date":"2024-10-04","current":-0.550192,"twenty":-0.753192,"median":-0.617503,"eighty":-0.271351,"marketCap":10506419},{"date":"2024-10-11","current":-0.709395,"twenty":-0.747173,"median":-0.61695,"eighty":-0.273408,"marketCap":13546534},{"date":"2024-10-18","current":-0.715771,"twenty":-0.747173,"median":-0.617853,"eighty":-0.273864,"marketCap":13668300},{"date":"2024-10-25","current":-0.738089,"twenty":-0.753192,"median":-0.622321,"eighty":-0.273941,"marketCap":14094483},{"date":"2024-10-31","current":-0.679106,"twenty":-0.748381,"median":-0.624396,"eighty":-0.27396,"marketCap":12968142},{"date":"2024-11-08","current":-0.640545,"twenty":-0.745065,"median":-0.622537,"eighty":-0.275816,"marketCap":10471927},{"date":"2024-11-15","current":-0.829168,"twenty":-0.759069,"median":-0.624396,"eighty":-0.277901,"marketCap":13555623},{"date":"2024-11-22","current":-0.913657,"twenty":-0.762487,"median":-0.624621,"eighty":-0.279209,"marketCap":14936883},{"date":"2024-11-29","current":-0.856676,"twenty":-0.764519,"median":-0.625706,"eighty":-0.280107,"marketCap":14005335},{"date":"2024-12-06","current":-0.817379,"twenty":-0.76969,"median":-0.626508,"eighty":-0.280711,"marketCap":13362889},{"date":"2024-12-13","current":-0.829168,"twenty":-0.776739,"median":-0.627998,"eighty":-0.281624,"marketCap":13555623},{"date":"2024-12-20","current":-0.80559,"twenty":-0.78119,"median":-0.630212,"eighty":-0.28455,"marketCap":13170155},{"date":"2024-12-27","current":-0.94706,"twenty":-0.790873,"median":-0.631609,"eighty":-0.287057,"marketCap":15482963},{"date":"2025-01-03","current":-1.002076,"twenty":-0.793132,"median":-0.632898,"eighty":-0.287745,"marketCap":16382388},{"date":"2025-01-10","current":-0.846852,"twenty":-0.798459,"median":-0.634232,"eighty":-0.291564,"marketCap":13844724},{"date":"2025-01-17","current":-0.978497,"twenty":-0.80559,"median":-0.636967,"eighty":-0.296053,"marketCap":15996920},{"date":"2025-01-24","current":-1.002076,"twenty":-0.806286,"median":-0.637223,"eighty":-0.297266,"marketCap":16382388},{"date":"2025-01-31","current":-0.894009,"twenty":-0.818165,"median":-0.638773,"eighty":-0.300285,"marketCap":14615660},{"date":"2025-02-07","current":-0.943186,"twenty":-0.828084,"median":-0.639809,"eighty":-0.302205,"marketCap":15419630},{"date":"2025-02-14","current":-0.876537,"twenty":-0.836575,"median":-0.639887,"eighty":-0.304385,"marketCap":14330020},{"date":"2025-02-21","current":-0.85432,"twenty":-0.841371,"median":-0.640128,"eighty":-0.306168,"marketCap":13966817},{"date":"2025-02-28","current":-0.852301,"twenty":-0.844751,"median":-0.641158,"eighty":-0.306801,"marketCap":13933798},{"date":"2025-03-07","current":-0.773533,"twenty":-0.844418,"median":-0.645889,"eighty":-0.307818,"marketCap":12646077},{"date":"2025-03-14","current":-0.73314,"twenty":-0.843192,"median":-0.646941,"eighty":-0.311806,"marketCap":11985708},{"date":"2025-03-21","current":-0.826045,"twenty":-0.841371,"median":-0.648137,"eighty":-0.31585,"marketCap":13504558},{"date":"2025-03-28","current":-0.923921,"twenty":-0.841371,"median":-0.649154,"eighty":-0.316592,"marketCap":14363038},{"date":"2025-04-04","current":-0.996294,"twenty":-0.84556,"median":-0.649444,"eighty":-0.327823,"marketCap":15488124},{"date":"2025-04-11","current":-0.887211,"twenty":-0.850782,"median":-0.649539,"eighty":-0.347439,"marketCap":13792344},{"date":"2025-04-17","current":-1.013262,"twenty":-0.85189,"median":-0.649841,"eighty":-0.354862,"marketCap":15751912}],"updateTime":1745056622089}}}